These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 25647573)
1. Targeting carbonic anhydrase IX activity and expression. Mahon BP; Pinard MA; McKenna R Molecules; 2015 Jan; 20(2):2323-48. PubMed ID: 25647573 [TBL] [Abstract][Full Text] [Related]
2. Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs. Thiry A; Supuran CT; Masereel B; Dogné JM J Med Chem; 2008 Jun; 51(11):3051-6. PubMed ID: 18348513 [No Abstract] [Full Text] [Related]
3. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Thiry A; Dogné JM; Masereel B; Supuran CT Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620 [TBL] [Abstract][Full Text] [Related]
4. Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties. Genis C; Sippel KH; Case N; Cao W; Avvaru BS; Tartaglia LJ; Govindasamy L; Tu C; Agbandje-McKenna M; Silverman DN; Rosser CJ; McKenna R Biochemistry; 2009 Feb; 48(6):1322-31. PubMed ID: 19170619 [TBL] [Abstract][Full Text] [Related]
5. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII. Rodríguez OM; Maresca A; Témpera CA; Bravo RD; Colinas PA; Supuran CT Bioorg Med Chem Lett; 2011 Aug; 21(15):4447-50. PubMed ID: 21723123 [TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target. De Simone G; Supuran CT Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200 [TBL] [Abstract][Full Text] [Related]
7. Efficient Expression and Crystallization System of Cancer-Associated Carbonic Anhydrase Isoform IX. Leitans J; Kazaks A; Balode A; Ivanova J; Zalubovskis R; Supuran CT; Tars K J Med Chem; 2015 Nov; 58(22):9004-9. PubMed ID: 26522624 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of carbonic anhydrase IX: a new strategy against cancer. Winum JY; Scozzafava A; Montero JL; Supuran CT Anticancer Agents Med Chem; 2009 Jul; 9(6):693-702. PubMed ID: 19601749 [TBL] [Abstract][Full Text] [Related]
10. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII. Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions. Chen F; Licarete E; Wu X; Petrusca D; Maguire C; Jacobsen M; Colter A; Sandusky GE; Czader M; Capitano ML; Ropa JP; Boswell HS; Carta F; Supuran CT; Parkin B; Fishel ML; Konig H J Cell Mol Med; 2021 Dec; 25(24):11039-11052. PubMed ID: 34791807 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204 [TBL] [Abstract][Full Text] [Related]
13. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. McDonald PC; Winum JY; Supuran CT; Dedhar S Oncotarget; 2012 Jan; 3(1):84-97. PubMed ID: 22289741 [TBL] [Abstract][Full Text] [Related]
14. Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors. Mahon BP; Hendon AM; Driscoll JM; Rankin GM; Poulsen SA; Supuran CT; McKenna R Bioorg Med Chem; 2015 Feb; 23(4):849-54. PubMed ID: 25614109 [TBL] [Abstract][Full Text] [Related]
15. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505 [TBL] [Abstract][Full Text] [Related]
16. Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes. Moeker J; Peat TS; Bornaghi LF; Vullo D; Supuran CT; Poulsen SA J Med Chem; 2014 Apr; 57(8):3522-31. PubMed ID: 24689792 [TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase IX as a target for metastatic disease. Gieling RG; Williams KJ Bioorg Med Chem; 2013 Mar; 21(6):1470-6. PubMed ID: 23098607 [TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Zatovicova M; Jelenska L; Hulikova A; Csaderova L; Ditte Z; Ditte P; Goliasova T; Pastorek J; Pastorekova S Curr Pharm Des; 2010; 16(29):3255-63. PubMed ID: 20819068 [TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX inhibitors in cancer therapy: an update. Supuran CT; Winum JY Future Med Chem; 2015; 7(11):1407-14. PubMed ID: 26230880 [TBL] [Abstract][Full Text] [Related]
20. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII. Guler OO; De Simone G; Supuran CT Curr Med Chem; 2010; 17(15):1516-26. PubMed ID: 20166929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]